4.0
8 Mar 2024
Former employee, more than 1 year
Enschede
Recommend
CEO approval
Business outlook
Pros
- Versatile projects/collaboration with various biotechnology companies - Hands-on experience
Cons
- Agile way process should be rolled out for more structured way of working